Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier and get daily trading ideas and historical data downloads. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

C O N M E D Corp (CNMD)

C O N M E D Corp (CNMD)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

C O N M E D Corp 11311 CONCEPT BOULEVARD LARGO FL 33773 USA

www.conmed.com Employees: 3,900 P: 727-392-6464

Sector:

Medical

Description:

CONMED Corporation is a major medical products manufacturer specializing in surgical instruments and devices for minimally invasive procedures and monitoring. A significant portion of the company's revenues are derived from products designed for the orthopedic surgery markets of arthroscopy and powered surgical instruments. The company also sells products for general and other surgical specialties such as electrosurgery systems for all types of surgery, and endosurgery instruments for minimally invasive laparoscopic surgery. Patient Care products, including ECG electrodes for heart monitoring and pulse oximetry for blood oxygenation monitoring, are provided for various clinical settings.The company operates in two revenue segments: Orthopedic Surgery and General Surgery.

Key Statistics

Overview:

Market Capitalization, $K 1,622,803
Enterprise Value, $K 2,504,133
Shares Outstanding, K 30,940
Annual Sales, $ 1,307 M
Annual Net Income, $ 132,420 K
Last Quarter Sales, $ 321,260 K
Last Quarter Net Income, $ 6,040 K
EBIT, $ 181,280 K
EBITDA, $ 258,840 K
60-Month Beta 1.20
% of Insider Shareholders 3.10%
Float, K 29,981
% Float 96.90%
Short Volume Ratio 0.47

Growth:

1-Year Return -18.79%
3-Year Return -45.41%
5-Year Return -33.83%
5-Year Revenue Growth 36.85%
5-Year Earnings Growth 57.95%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings 0.95 on 04/30/25
Next Earnings Date 07/30/25 [AMC]
Earnings Per Share ttm 4.32
EPS Growth vs. Prev Qtr -29.10%
EPS Growth vs. Prev Year 20.25%
Annual Dividend Rate, $ 0.80
Annual Dividend Yield 1.53%
Most Recent Dividend 0.200 on 06/13/25
Next Ex-Dividends Date 06/13/25
Dividend Payable Date 07/03/25
Dividend Payout Ratio 18.34%
Most Recent Split 3-2 on 09/10/01

CNMD Ratios

Ratio
Price/Earnings ttm 12.02
Price/Earnings forward 11.76
Price/Earnings to Growth 1.34
Return-on-Equity % 14.36%
Return-on-Assets % 5.86%
Profit Margin % 10.13%
Debt/Equity 0.91
Price/Sales 1.23
Price/Cash Flow 7.73
Price/Book 1.64
Book Value/Share 31.60
Interest Coverage 5.37

CNMD Dividends

Date Value
06/13/25 $0.2000
03/14/25 $0.2000
12/20/24 $0.2000
09/16/24 $0.2000
06/14/24 $0.2000
03/14/24 $0.2000
12/15/23 $0.2000
09/14/23 $0.2000
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar